ReviewChinese medical journal pulmonary and critical care medicine2023

HER3-targeted therapeutic antibodies and antibody-drug conjugates in non-small cell lung cancer refractory to EGFR-tyrosine kinase inhibitors.

Margaret E Larsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.